Потребителски вход

Запомни ме | Регистрация
Постинг
29.12.2016 21:44 - Най-доброто средство за унищожаване на грипа
Автор: apollon Категория: Изкуство   
Прочетен: 1291 Коментари: 4 Гласове:
10

Последна промяна: 01.05 12:09

Постингът е бил сред най-популярни в категория в Blog.bg Постингът е бил сред най-популярни в Blog.bg
Всички в края на този декември са болни. Това се случи през 2016 лето Господне. Само аз и неколцина останаха здрави по една истинска случайност. Приемах препарата неокс, на който му минаваше срока и който съдъжаше ситно смлени частици от семената на сминдух. Латинското име на растението е Trigonella foenum-graecum L. Семената от бобовете на тази тревиста билка се оказва, че действат силно токсично на цял ред насекоми, за които те биха били достъпна храна и следователно никой бръмбар на земята, нито неговите ларви не могат да се развият или хранят от тях. В това се крие биологическия смисъл на растението. Освен това растението намалява кръвната захар, действа апетитовъзбуждащо,, разхлабващо и увеличава мъжката потентност. При жените увеличава лактацията. Намалява холестерола и липидите. Действа противовъзпалително на стомаха и червата.
Други два люти метода за предпазване от грип са употребата на чай от джинджифил или резени за смучене, както и резени от скилидка чесън, защото действат вирусоцидно в устната кухина, откъдето заразата навлиза в организма най-вече по въздушно-капков път.
На български билката се казва още гръцко сено.




Статия за активиране на имунната система при мишки от водни екстракти на гръцко сено:
Immunomodulatory effects of fenugreek
(Trigonella foenum graecum L.) extract in mice
Bilal Bin-Hafeez, Rizwanul Haque, Suhel Parvez, Suwarna Pandey,
Iqbal Sayeed 1, S. Raisuddin*
Department of Medical Elementology and Toxicology, Jamia Hamdard, Hamdard University, New Delhi 110 062, India
Received 19 April 2002; received in revised form 20 July 2002; accepted 13 December 2002
Abstract
Immunomodulatory activity of aqueous extract of Trigonella foenum graecum L., a widely used medicinal and dietary
herb, was evaluated in male Swiss albino mice. Mice were treated with three doses of extract (50, 100 and 250 mg/kg body
weight per os) for 10 days. Body weight, relative organ weight, cellularity of lymphoid organs, delayed type of
hypersensitivity (DTH) response, plaque-forming cell (PFC) assay, haemagglutination titre (HT), quantitative haemolysis of
SRBC (QHS) assay, phagocytosis, and lymphoproliferation were studied in various groups of animals. At doses of 50 and
100 mg/kg, a significant increase ( p < 0.05) in relative organ weight of thymus was observed but there was no effect on
kidney and spleen weights. Liver weight also increased significantly at doses of 100 and 250 mg/kg. However, no elevation
in the levels of liver function test (LFT) enzymes was observed. As regards lymphoid organ cellularity, spleen recorded no
significant increase at any dose, whereas cellularities of thymus and bone marrow were significantly increased. T. foenum
graecum extract elicited a significant ( p < 0.001) increase in the DTH response at doses of 50 and 100 mg/kg, but the change
at higher dose of 250 mg/kg was not statistically significant. Humoral immunity as measured by PFC showed an elevated
response at a dose of 100 mg/kg, but at 50 and 250 mg/kg, no significant effect was observed. In the HT test, plant extract
also showed modulatory effect at all the doses. Plant extract elicited a significant increase in phagocytic index and
phagocytic capacity of macrophages. Stimulatory response of plant extract was also observed in lymphoproliferation assay
but the response was weak. Overall, T. foenum graecum showed a stimulatory effect on immune functions in mice. As it is
used for a variety of medicinal purposes, its immunostimulatory effect, as reported in this study, strengthens the rationale of
its use in several Ayurvedic and Unani drugs.
D 2002 Elsevier Science B.V. All rights reserved.
Keywords: Trigonella foenum graecum; Immunomodulation; Traditional medicine systems; Immunosuppression
1. Introduction
A large number of plants and their isolated
constituents have been shown to potentiate immunity
[1,2]. Some medicinal plants have been shown
to exert anti-inflammatory, anti-stress and anti-can-
1567-5769/02/$ - see front matter D 2002 Elsevier Science B.V. All rights reserved.
doi:10.1016/S1567-5769(02)00292-8
* Corresponding author. Tel.: +91-11-26059688x5568;
fax: +91-11-26059663.
E-mail address: sraisuddin@hotmail.com (S. Raisuddin).
1 Present address: Department of Neurology, University of
Magdeburg, Leipziger Str., 44d-39120, Magdeburg, Germany.
www.elsevier.com/locate/intimp
International Immunopharmacology 3 (2003) 257–265
cer effects by modulating the immune functions
[3,4]. We have reported protective effect of Cassia
occidentalis and Emblica officinalis Gaertn against
cyclophosphamide (CP)-induced suppression of
humoral immunity in mice [5,6]. It was also found
that C. occidentalis, E. Officinalis and Cassia
cinnamon have antimutagenic effects against benzo[
a]pyrene and CP-induced mutagenicity [7–10].
Besides source of medicine, these plants are used as
dietary constituents in India and other Afro-Asian
countries.
Fenugreek (Trigonella foenum graecum L.; family
Leguminoceae) is one such plant whose seeds
and leaves are used not only as food but also as an
ingredient in traditional medicine. Seeds of fenugreek
are used as a condiment and as a supplement
to wheat and maize flour for bread making and as a
constituent of the daily diet of general population in
Indian subcontinent. Its leaves are consumed widely
in India as a green leafy vegetable and are a rich
source of calcium, iron, h-carotene and other vitamins
[11]. Seeds of T. foenum graecum contain
tannic acid, fixed and volatile oils and a bitter
extractive, diosgenin, alkaloids trigonelline, trigocoumarin,
trigomethyl coumarin, and steroidal saponin
such as gitogenin and traces of trigogenin and
vitamin A [12,13].
Some of the therapeutic uses of T. foenum
graecum include its use as hypoglycemic, antiulcerogenic,
hypocholesterolemic and antihypertensive
agent [11,14,15]. In Ayurvedic and Unani
systems of medicine, fenugreek is used for the
treatment of epilepsy, paralysis, gout, dropsy,
chronic cough and piles [16]. In the present communication,
we report its immunomodulatory effects
in mice.
2. Materials and methods
2.1. Plant extract
Total aqueous extract of T. foenum graecum in
semisolid form was procured from the Plant Extract
Division of Saiba Industries, Mumbai. A certificate of
authenticity was provided along with the extract. The
chemical analysis report provided by the manufacturers
showed no presence of endotoxin.
2.2. Chemicals
Antibiotic antimycotic solution (100), bovine
serum albumin (BSA), fetal bovine serum (FBS),
Hank’s balanced salt solution (HBSS), Histopaque-
1077, phosphate-buffered saline (PBS) and RPMI-
1640 medium were purchased from Sigma, St. Louis,
MO. Petroleum jelly was obtained from Hi-Media
Labs, Mumbai, conconvalin A (Con A) from Banglore
Genei (India) and solvents from BDH, Mumbai;
tritiated [3H]-thymidine was purchased from Amersham
Pharmacia Biotech UK, Bukinghamshire.
2.3. Animals
Study was conducted in Swiss albino male mice
(30–35 g). Female guinea pigs (250 g) were used for
the preparation of complement for plaque-forming cell
(PFC) assay. The Central Animal House Facility of the
University provided the animals. The animals were
bred and maintained under standard laboratory conditions
(temperature 25F2 jC; photoperiod of 12 h).
Commercial pellet diet and water were given ad
libitum.
2.4. Dosage
The plant extract was suspended in normal saline
and was administered orally for 10 days at doses of 50,
100 and 250 mg/kg body weight. The dose volume
was 0.2 ml. Control animals received the same volume
of normal saline.
2.5. Body weight, lymphoid organ weight and
cellularity
Animals were divided into four groups (I–IV).
Each group comprised of a minimum of five animals.
Group I (control) received normal saline;
group II, plant extract 50 mg/kg body weight; group
III, plant extract 100 mg/kg; and group IV, plant
extract 250 mg/kg. The animals were humanized 24
h after the last dose. Body weight gain (percentage)
and relative organ weight (organ weight/100 g of
body weight) of kidney, liver, spleen and thymus
were determined for each animal. Single cell suspensions
were prepared in RPMI-1640 medium from
bone marrow (from femur), spleen and thymus for
258 B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265
cell count. Cell counting was done by using the
Neubauer chamber [17].
2.6. Assessment of humoral immune functions
Animals of all the groups treated in the abovedescribed
manner were challenged with 0.2 ml of 10%
sheep red blood cells (SRBC), i.p. on the 10th day of
initiation of experiment. The following parameters of
humoral immunity were studied in those animals.
2.6.1. Haemagglutinin titre (HT) assay
HT assay was performed using the procedure of
Bin-Hafeez et al. [5]. On the fifth day after immunization,
blood was collected from orbital plexus of
each mouse for serum preparation. Serial twofold
dilution of serum was made in 50 Al of PBS (pH 7.2)
in 96-well microtitre plates (Tarsons Products, Calcutta)
and mixed with 50 Al of 1% SRBC suspension in
PBS. After mixing, plates were kept at room temperature
for 2 h. The value of antibody titre was assigned to
the highest serum dilution showing visible haemagglutination.
2.6.2. Plaque-forming cell assay
The PFC assay was performed using the method of
Raisuddin et al. [18]. The animals were humanized on
the fifth day of immunization with SRBC. The spleen
was removed, cleaned free of extraneous tissues, and a
single cell suspension of 106 cells/ml was prepared
from it in RPMI-1640 medium. For PFC assay, the
SRBC were prepared at a cell density of 5108 cells/
ml in PBS. One milliliter of SRBC in medium along
with 0.5 ml of diluted guinea pig complement (1:10
diluted with normal saline) was added to 1 ml of
spleen cell suspension. Cuningham chambers were
prepared using glass slide, coverslips and doublesided
tape (Scotch Brand, St. Paul, MN). The chambers
were loaded with a known volume of assay
mixture, sealed with petroleum jelly and incubated
at 37 jC for 1 h. The plaques were counted under a
light microscope (Olympus BX50) and expressed as
PFC per 106 spleen cells.
2.6.3. Quantitative haemolysis of SRBC (QHS) assay
QHS assay was performed using the methods of
Simpson and Gozo [19] with some modification [5].
Spleens were removed and a cell suspension of
1106/ml was prepared in PBS. One milliliter of
0.2% SRBC and 1 ml of 10% guinea pig serum were
mixed with cell suspension and incubated for 1 h at
37 jC. After centrifugation at 3000 rpm for 3 min,
optical density of the supernatant was measured at
413 nm using a spectrophotometer (Shimadzu UV-
1201).
2.7. Assessment of cellular immune function
For assessment of cellular immune function, delayed
type of hypersensitivity (DTH) response was
evaluated in the extract-treated mice. Four groups of
animals were treated as described above.
2.7.1. Delayed type of hypersensitivity response
The DTH response was determined using the
method of Raisuddin et al. [18]. On the day of
termination of the treatment, animals were immunized
with 1109 SRBC, subcutaneously. On the fifth day
of immunization, all the animals were again challenged
with 1108 cells in the left hind footpad. The
right footpad injected with the same volume of normal
saline served as trauma control for nonspecific swelling.
Increase in footpad thickness was measured 24 h
after the challenge using dial caliper (Guanglu,
China).
2.8. Assessment of nonspecific immune functions
For assessment of nonspecific immune functions,
phagocytic activity of macrophages was studied. Four
groups of animals were treated as described above.
2.8.1. Phagocytic activity of macrophages
The phagocytic activity of peritoneal macrophages
was evaluated using the suspension assay as described
by Fujiki and Yano [20] with some modification.
Briefly, 0.1 ml of aliquot of cells having density of
10106 cells/ml was mixed with 0.1 ml RPMI-1640
medium containing 20% FCS and 100106 cells/ml
heat-treated yeast (Saccharomyces cereviceae) cells.
The mixture was incubated at 37 jC for 1 h with
occasional shaking. After incubation, 50 Al of this
mixture was smeared on the glass slide, air dried and
stained with Wright–Giemsa stain. The slides were
observed under light microscope using oil immersion.
At least 500 cells were counted. The phagocytic activ-
B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265 259
ity was expressed as phagocytic index (PI) and phagocytic
capacity (PC) using the following formulae.
PI ¼ AB
where A is the percentage of yeast-ingesting phagocytes
and B is the number of yeast-ingested per phagocytes;
PC is the mean percentage of cells that
engulfed z4 yeast cells.
2.8.2. Lymphocyte proliferation assay
For assessment of lymphocyte proliferation assay,
four groups of mice were treated as described above.
On completion of treatment blood was withdrawn
from retro-orbital plexus of mice. Lymphocytes were
isolated from the blood by density gradient centrifugation
on Histopaque-1077. The mononuclear cells
from the buffy coat were carefully pipetted out with a
sterilized Pasteur pipette and pelleted at 400g for
10 min. The cell pellet was suspended in 1 ml of
growth medium (RPMI-1640) containing 10% FBS
and recommended concentration of antibiotic and
antimycotic solution. The cell viability was assessed
by the trypan blue exclusion method and the cells
were plated in 96-well culture plates (Tarsons) at a
cell density of 1106 cells/well. ConA was used as a
mitogenic agent. The culture plate was incubated at
37 jC in CO2 (5%) incubator (Forma Scientific,
Ohio), with water-saturated air for 6 days. After 6
days the cells were pulsed with 1 ACi of [3H]-methylthymidine.
Cells were harvested after 18 h of radioactive
pulse and the amount of [3H]-thymidine incorporated
into DNA was determined by liquid
scintillation spectroscopy [21].
2.8.3. Liver function tests
Activities of serum glutamate oxalate transaminase
(SGOT) and serum glutamate pyruvate transaminase
(SGPT) were estimated by using the kits (Span
Diagnostics, Surat, India). For this purpose, four
groups of animals (one control + three treatments) as
described above were used and treated for 10 days
with respective doses of plant extract.
2.9. Statistical analysis
Data were statistically analyzed using Student’s ttest
to determine significant differences in the data of
various groups. P values less than 0.5 were considered
significant. The values are expressed as means
FS.E.
3. Results
3.1. Effect of plant extract on body weight, lymphoid
organ weight and cellularity
None of the doses of Trigonella extract showed
toxicity or mortality in the extract-treated animals.
No significant body weight gain differences were
recorded in various groups of animals (Table 1). No
effect was observed in the spleen weight at any
dose when compared with control (normal salinetreated)
animals (group I). At doses of 50 and 100
mg/kg, a significant increase ( p < 0.05) in relative
organ weight of thymus was observed but there was
no effect at a dose of 250 mg/kg in its weight. As
regard the relative organ weight of liver, a significant
( p < 0.001) increase was observed at doses of
Table 1
Effect of T. foenum graccum on the relative organ weights of mice
Group Relative organ weight (meansFS.E.) in grams
Spleen Thymus Liver Kidney
(I) Control 0.64F0.01 0.25F0.01 4.88F0.23 1.39F0.08
(II) Plant extract (50 mg/kg) 0.67F0.02 0.27F0.01a 5.29F0.14 1.31F0.04
(III) Plant extract (100 mg/kg) 0.72F0.08 0.28F0.01a 6.20F0.22b 1.36F0.03
(IV) Plant extract (250 mg/kg) 0.62F0.03 0.24F0.01 6.14F0.07b 1.36F0.05
Values are meansFS.E. of five mice.
a p < 0.05 when compared with group I (significantly different).
b p < 0.001 when compared with group I (significantly different).
260 B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265
100 and 250 mg/kg. This increase in liver weight
did not reflect any abnormality as assessed by LFT.
There was no significant elevation in the levels of
SGOT and SGPT as a result of treatment with T.
foenum graecum at any of the doses used in this
study.
Lymphoid organ cellularity (Table 2) data indicate
no significant increase in the spleen cellularity at any of
the doses. In the case of bone marrow, doses of 50 and
100 mg/kg showed a significant ( p < 0.01 and p < 0.05)
increase in cellularity. A significant (p<0.01) increase
was also recorded in the cellularity of thymus at doses
of 50 and 100 mg/kg as compared with control animals
(group I).
3.2. Effect of plant extract on humoral immunity
parameters
Effect of T. foenum graecum on humoral immunity
parameters viz., PFC assay and QHS assay, are
shown in Figs. 1 and 2, respectively. Plant extract
showed an elevated response at a dose of 100 mg/
kg, but at doses of 50 and 250 mg/kg, no effect
was observed in these parameters when the data
were compared with saline-treated control animals
(group I).
In haemmaglutination titre (Table 3), doses of 50,
100 and 250 mg/kg showed titre values of 1:1707,
1:2389 and 1:1621, respectively, while the titre value
of controls (group I) was 1:512, thus showing increase
in the titre values in all the treated groups.
Fig. 1. Effect of T. foenum graecum on the humoral immunity as
assessed by the plaque-forming cell assay. Data are meansFS.E. of
five animals; **p < 0.01 when compared with the control animals
(significantly different).
Table 2
Effect of T. foenum graecum on the cellularity of lymphoid organs
Group Cellularity (meansFS.E.106)
Spleen Thymus Bone Marrow
(I) Control 385.14F17.91 78.55F5.55 18.74F1.07
(II) Plant
extract
(50 mg/kg)
325.22F33.64 118.2F11.02a 28.24F2.0a
(III) Plant
extract
(100 mg/kg)
414.36F27.85 120.12F8.1a 25.98F2.4b
(IV) Plant
extract
(250 mg/kg)
380.66F60.43 100F9.12 16.46F1.75
Values are meansFS.E.106 of five mice.
a p < 0.01 when compared with group I (significantly different).
b p < 0.05 when compared with group I (significantly different).
Fig. 2. Effect of T. foenum graecum on the humoral immunity as
assessed by the quantitative hemolysis of SRBC assay. Data are
meansFS.E. of five animals; **p < 0.001 when compared with the
control animals (significantly different).
Table 3
Effect of T. foenum graecum on antibody titre in mice
Group Titre level
(I) Control 1:512
(II) Plant extract (50 mg/kg) 1:1707
(III) Plant extract (100 mg/kg) 1:2389
(IV) Plant extract (250 mg/kg) 1:1621
B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265 261
3.3. Effect of plant extract on cell-mediated immunity
parameters
Plant extract at doses of 50, 100 and 250 mg/kg
elicited a significant ( p < 0.01 to p < 0.001) increase in
DTH response (Table 4) as compared to control
animals (group I).
3.4. Effect of plant extract on phagocytic activity of
macrophages
The results of effect of T. foenum graecum on
macrophage functions are presented in Figs. 3 and
4. Plant extract at a dose of 100 mg/kg body weight
showed significant increase in phagocytic index
( p < 0.01) and phagocytic capacity ( p < 0.001) when
the results were compared with control animals
(group I). While the dose of 250 mg/kg elicited a
significant ( p < 0.05) increase in the phagocytic
capacity, no effect was observed in phagocytic
index at this dose, and there was no significant
effect at the dose of 50 mg/kg on either of the parameters.
3.5. Effect of plant extract on lymphocyte proliferation
Although plant extract elicited stimulatory effect in
lymphoproliferative assay as assessed by [3H]-thymidine
incorporation at all the doses (Table 5), effect
was significant ( p < 0.05) at the dose of 250 mg/kg
only.
Table 4
Effect of T. foenum graecum on delayed type of hypersensitivity
response in mice
Group Foot pad thickness
(in mm) (meansFS.E.)
(I) Control 0.91F0.18
(II) Plant extract (50 mg/kg) 1.26F0.10a
(III) Plant extract (100 mg/kg) 1.08F0.09b
(IV) Plant extract (250 mg/kg) 1.61F0.11a
Values are meansFS.E. of five mice.
a p < 0.001 when compared with control group (significantly
different).
b p<0.01 when compared with control group (significantly
different).
Fig. 3. Effect of T. foenum graecum on the nonspecific immunity as
assessed by the phagocytic index. Data are meansFS.E. of five
animals; **p < 0.01 when compared with the control animals
(significantly different).
Fig. 4. Effect of T. foenum graecum on the nonspecific immunity as
assessed by the phagocytic capacity. Data are meansFS.E. of five
animals; *p < 0.05 and **p < 0.01 when compared with the control
animals (significantly different).
Table 5
Effect of T. foenum graecum on Con A-induced blood lymphocyte
proliferation
Groups CPM (meansFS.E.)
(I) Control (Con A only) 8028F514.25
(II) Plant extract (50 mg/kg) + Con A 8218F477
(III) Plant extract (100 mg/kg) + Con A 8852F654
(IV) Plant extract (250 mg/kg) + Con A 9678F523a
Values are meansFS.E. of five mice.
a p < 0.05 when compared with control group (significantly
different).
262 B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265
4. Discussion
Fenugreek has primarily been described as an antihyperglycemic
herb in humans as well as in laboratory
animals [22,23]. Its cholesterol-reducing effect is also
well established [24]. In the present study, fenugreek
showed an overall stimulatory effect on the specific as
well as nonspecific immune functions in mice. Stimulatory
effects were observed at 100 mg/kg body
weight dose and in some cases at 250 mg/kg. Though
there was an increase in liver weight, estimation of the
LFT enzymes did not reflect any toxicity. Similarly,
Muralidhara et al. [25] have shown that debitterized
fenugreek powder did not alter GOT, GPT and alkaline
phosphates (ACP) levels either in serum or liver
in rats maintained on 1%, 5% and 10% debitterized
fenugreek powder up to 90 days. However, in contrast
to our observation, they did not report any significant
increase in the liver weight of treated animals.
Plant extract at doses of 50 and 100 mg/kg
increased the bone marrow cell counts indicating its
stimulatory effect on haematopoietic stem cells of
bone marrow. A similar effect of C. occidentalis and
E. officinalis has been observed in our previously
reported studies [5,6]. In most of the parameters
studied, 100 mg/kg dose was most effective in inducing
the immune functions. It appears that 100 mg/kg is
the optimum dose in mice. An increase in dose might
have induced down-regulation of immune functions.
Thus, 100 mg/kg dose of T. foenum graecum seems to
be pharmacologically effective dose in mouse as far as
immunomodulatory effects are concerned. The
response at the higher dose, i.e. at 250 mg/kg, was
either identical to control group animals or mildly
stimulated as compared to control animals. The
increase in thymus weight was accompanied by
increase in its cell counts. This may be partly due to
stimulatory effect of plant extract on the lymphocytes
and bone marrow haematopoietic cells, which ultimately
home in the thymus. However, this homing
may be temporary and in due course of time normalcy
may ensue. Further detailed investigations may throw
light on this aspect.
The main chemical constituents of T. foenum
graecum are fibers, flavonoids, polysaccharides, saponins,
flavonoids and polysaccharides fixed oils and
some identified alkaloids viz., trigonelline and choline
[12,26]. Saponins, in particular, are described as
immunostimulating agents [27]. It is suggested that
some of the constituents might be having mitogenic
effects, which in turn lead to stimulatory effects on the
immunocompetent cells. Some of these constituents
also possess antioxidant properties and they may
induce the immunostimulant effect as several antioxidants
have been reported to possess immunomodulatory
properties [28–30]. Comparison has been made
between T. foenum graecum and that of cod liver oil,
and a striking similarity has been noted [31]. The
presence of trimethylamine, neurin and betain alkaloids
has also been reported in T. foenum graecum.
These constituents are also present in cod liver oil and
are believed to stimulate the appetite by their action
on nervous system, or produce a diuretic or ureopoietic
effect.
T. foenum graecum showed stimulatory effects on
macrophages. Phagocytosis and killing of invading
microorganisms by macrophages constitute body’s
primary line of defense against infections [32]. Macrophages
are an integral part of the immune system,
acting as phagocytic, microbicidal and tumoricidal
effector cells. Through interaction with lymphocytes,
macrophages play an important role in the initiation
and regulation of immune response [33,34]. Most of
the plants so far reported for immunomodulatory
effects have major effects on nonspecific immunity,
i.e. macrophages functions [35–38]. Fenugreek seeds
are rich source of dietary fiber. These fibers may not
only be helpful in reducing blood sugar but their
stimulatory effects on macrophages can also be not
ruled out [39]. High quantity of mucilage (about 28%)
reported in fenugreek also may partly be responsible
for an inducing effect on macrophages [31]. Fenugreek
also contains considerable quantities of iron in
an organic form, which may be readily absorbed
[31,40]. This seems to facilitate haematopoietic stimulation
in bone marrow as observed in the present
study.
Findings of the present study establish that T.
foenum graecum has appreciable immunostimulatory
activity. It is already reported for various medicinal
activities such as antidiabetogenic, anticulminative,
antinoceceptive, antihypocholesterolemic, etc. It is
not possible at this juncture to single out the most
effective immunostimulatory constituent of T. foenum
graecum. However, based on the published
studies, saponins, fibers and flavonoids seem to be
B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265 263
most likely candidates eliciting immunostimulating
effect. Administration of fenugreek in human is
simple as its seeds and leaves are used as common
dietary constituents in Indian household. Its reported
immunomodulatory effects warrant further investigation
for its use in the cases of clinical immunosuppression.
Acknowledgements
We gratefully acknowledge financial support
received from the Central Council for Research in
Unani Medicine (CCRUM, Government of India) for
this study. We also thank Dr. Shamshad Ahmad Khan,
Assistant Director, CCRUM, for his valuable suggestions.
Assistance of Mr. Razi Ahmad is also acknowledged.
References
[1] Savnur HV. A handbook of Ayurvedic materia medica with
principles of pharmacology and therapeutics. Belagaum: Dr.
Jaghat & Sons; 1950.
[2] Bhagwandash V. Fundamentals of Ayurvedic medicine. Delhi:
Bansal & Co.; 1978. p. 9 –16.
[3] Singh GB, Atal CK. Pharmacology of an extract of salai gugal
ex-Boswellia serrata, new non-steroidal anti-inflammatory
agents. Agents Actions 1986;8:407–12.
[4] Thatte UM. Ayurveda: an important source of medicine. Indian
J Clin Pract: Medinews 1996;5:18.
[5] Bin Hafeez B, Ahmad I, Haque R, Raisuddin S. Protective
effect of Cassia occidentalis L. on cyclophosphamide-induced
suppression of humoral immunity in mice. J Ethnopharmacol
2001;75:13–8.
[6] Haque R, Bin-Hafeez B, Ahmad I, Parvez S, Pandey S,
Raisuddin S. Protective effects of Emblica officinalis Gaertn.
in cyclophosphamide treated mice. Hum Exp Toxicol
2001;20:643– 50.
[7] Sharma N, Trikha P, Athar M, Raisuddin S. Protective effect
of Cassia occidentalis extract on chemical-induced chromosomal
aberrations in mice. Drug Chem Toxicol 1999;22:
643– 53.
[8] Sharma N, Trikha P, Athar M, Raisuddin S. In vitro inhibition
of carcinogen-induced mutagenicity by Cassia occidentalis
and Emblica officinalis. Drug Chem Toxicol 2000;23:
477– 84.
[9] Sharma N, Trikha P, Athar M, Raisuddin S. Inhibitory effect
of Emblica officinalis on the in vivo clastogenicity of benzo[
a]pyrene and cyclophosphamide in mice. Hum Exp Toxicol
2000;19:377–84.
[10] Sharma N, Trikha P, Athar M, Raisuddin S. Inhibition of
benzo[a]pyrene- and cyclophosphamide-induced mutagenicity
by Cinnamomum cassia. Mutat Res 2001;480–481:179– 88.
[11] Sharma RD, Sarkar A, Hazra DK. Hypolipidaemic effect of
fenugreek seeds: a chronic study in non-insulin dependent
diabetic patient. Phytother Res 1996;10:332– 4.
[12] Jayaweera DMA. Medicinal plant: Part III. Peradeniya, Sri
Lanka: Royal Botanic Garden; 1981. p. 255.
[13] Petit PR, Sauviaire YD, Hillaire-Buys DM, Leconte OM,
Baissac YG, et al. Steroid saponins from fenugreek seeds:
extraction, purification and pharmacological investigation on
feeding behavior and plasma cholestrol. Steroids 1995;10:
674–80.
[14] Kirtikar KR, Basu BD. Indian medicinal plants, 2nd ed. Delhi:
Periodicals Experts; 1935.
[15] Tayyaba Z, Hasnain SN, Hasan SK. Evaluation of the oral
hypoglycemic effects of Trigonella foenum graecum L. (Methi)
in normal mice. J Ethnopharmacol 2001;75:191– 5.
[16] CCRUM Standardisation of single drugs of Unani medicine:
Part I. New Delhi: Central Council for Research in Unani Medicine,
Ministry of Health & Family Welfare, Govt. of India.
[17] Raisuddin S, Singh KP, Zaidi SIA, Saxena AK, Ray PK.
Effects of aflatoxin on lymphoid cells of weanling rat. J Appl
Toxicol 1990;10:245–50.
[18] Raisuddin S, Zaidi SIA, Singh KP, Ray PK. Effect of subchronic
aflatoxin exposure on growth and progression of Ehrlich’s
ascites tumor in mice. Drug Chem Toxicol 1991;14:
185–206.
[19] Simpson MA, Gozzo JJ. Spectrophotometric determination of
lymphocyte mediated sheep red blood cell hemolysis in vitro.
J Immunol Methods 1978;21:159– 65.
[20] Fujiki K, Yano T. Effect of sodium alginate on the non-specific
defense system of the common carp (Cyprinus caprio
L.). Fish Shellfish Immunol 1997;7:417–27.
[21] Raisuddin S, Singh KP, Zaidi SIA, Paul BN, Ray PK. Immunosuppressive
effects of aflatoxin in growing rats. Mycopathologia
1993;124:189–94.
[22] Bordia A, Verma SK, Srivastava KC. Effect of ginger (Zinger
officinale Rosc) and fenugreek (Trigonella foenum graecum
L.) on blood lipids, blood sugar and platelet aggregation in
patients with coronary heart disease. Prostaglandins Leukot
Essent Fat Acids 1997;56:379–84.
[23] Sharma RD, Raghuram TC, Rao NS. Effect of fenugreek
seeds on blood glucose and serum lipids in type I diabetes.
Eur J Clin Nutr 1990;44:301–6.
[24] Sharma RD. Hypocholesterolemic activity of fenugreek (T.
foenum graecum). An experimental study in rats. Nutr Rep
Int 1984;30:221– 31.
[25] Muralidhara, Narsimhamurthy K, Viswanatha S, Ramesh BS.
Acute and subchronic toxicity assessment of debitterized fenugreek
powder in the mouse and rat. Food Chem Toxicol
1999;37:831– 8.
[26] Yoshikawa M, Murakami T, Komatsu H, Murakami N, Yamahara
J, Matsuda H. Medicinal foodstuffs: IV. Fenugreek seeds.
(1): structures of trigoneosides Ia, Ib, IIb, IIIa, and IIIb, new
furostanol saponins from the seeds of Indian Trigonella foenum
graecum L. Chem Pharmacol Bull 1997;45:81 –7.
[27] Liu J, Wang S, Liu H, Yang L, Nan G. Stimulatory effect of
264 B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265
saponin from Panax ginseng on immune function of lymphocytes
in the elderly. Mech Ageing Dev 1995;83:43–53.
[28] de La Fuente M, Victor VM. Anti-oxidants as modulators of
immune function. Immunol Cell Biol 2000;78:49– 54.
[29] Ruby AJ, Kuttan G, Babu KD, Rajasekharan KN, Kuttan R.
Anti-tumor and anti-oxidant activity of natural curcuminoids.
Cancer Lett 1995;94:79– 85.
[30] Devasagayam TPA, Sainis KB. Immune system and antioxidants,
especially those derived from Indian medicinal plants.
Indian J Exp Biol 2002;40:639–55.
[31] http://www.botanical.com/botanical/mgmh/f/fenugr07.html.
[32] VanFurt R. Current view on the mononuclear phagocyte system.
Immunobiology 1982;161:178– 85.
[33] Albercht RM. Macrophages in the immune response. In: Baram
P, Battisto J, Pierce C, editors. Immunologic tolerance and
macrophage function. Amsterdam: Elsevier; 1979. p. 81– 91.
[34] Kende M. Role of macrophages in the expression of immune
responses. J Am Vet Med Assoc 1982;181:1037 –42.
[35] Yamaguchi H. Immunomodulation by medicinal plants. Adv
Exp Med 1992;319:287–97.
[36] Atal CK, Sharma ML, Kaul A, Khajuria A. Immunomodulating
agents of plants origin: I. Preliminary screening. J Ethnopharmacol
1986;18:133–41.
[37] Dhuley JN. Effects of some Indian herbs on macrophage functions
in ochratoxin-A treated mice. J Ethnopharmacol 1997;
58:15– 20.
[38] Puri A, Saxena R, Saxena RP, Saxena KC, Srivastava V, Tandon
JS. Immunostimulant activity of Nyctanthes arbor tristis
L. J Ethnopharmacol 1994;42:31 – 7.
[39] Dakroury AM, el-Galil A, el-Saadany SS, Parwish AH. Comparative
analysis of total proteins, aminoacids, carbohydrates,
fibers, lipids, macro and micro minerals contents in different
types of Egyptian bread. Nahrung 1986;30:3–9.
[40] Jonnalagadda SS, Seshadri S. In vitro availability of iron from
cereal meal with the addition of protein isolates and fenugreek
leaves. Plant Foods Hum Nutr 1994;45:119–25.
B. Bin-Hafeez et al. / International Immunopharmacology 3 (2003) 257–265 265
The author has requested enhancement of the downloaded file. All in-text references underlined in blue are linked to publications on ResearchGate.












Гласувай:
10
0


Вълнообразно


1. indiram - Здравей, Аполлон!
29.12.2016 21:53
Чесън е лекарството против грип!
Поздрави!
цитирай
2. apollon - Това е неоспорима пасторална кл...
29.12.2016 23:00
Това е неоспорима пасторална класика - аз се чудя защо високопланинските кози не боледуват от грип, а те хрупали планински чесън
цитирай
3. apollon - аз ти разправям, че шарената сол те ...
29.12.2016 23:37
аз ти разправям, че шарената сол те спасява от грип, ти пак си знаеш за чесъна. Поздрави Индиррамм.
цитирай
4. apollon - Изключително ценна информация за гръцкото сено
03.01 23:23
http://www.ijabbr/article_7851_bbd8fa7701b237d7746306a9df24e736.pdf
цитирай
Търсене

За този блог
Автор: apollon
Категория: Изкуство
Прочетен: 8558889
Постинги: 5135
Коментари: 9900
Гласове: 17430
Архив
Календар
«  Май, 2017  
ПВСЧПСН
1234567
891011121314
15161718192021
22232425262728
293031